New England Life Care, Inc. dba Advanced Compounding Solutions

FDA Regulatory Profile

New England Life Care, Inc. dba Advanced Compounding Solutions appears in FDA public data with 5 recalls, 0 510(k) clearances, 1 FDA inspection, and 1 compliance action on record. Its most recent recall (D-0928-2023, Class II) was initiated on July 10, 2023.

Summary

Total Recalls
5
510(k) Clearances
0
Inspections
1
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-0928-2023Class IIROcuronium Bromide 50 mg/5 mL ( 10 mg/mL), 5mL Syringe, RX Only, Advanced Compounding Solutions, 4 CJuly 10, 2023
D-0927-2023Class IIPHENYLephrine HCl 10mg added to 0.9% Sodium Chloride 250mL, 250 mL IV Bag @60 Total volume), RX onlyJuly 10, 2023
D-0929-2023Class IIVancomycin HCl 1.5 g added to 0.9% Sodium Chloride 500 mL, 500 mL IV Bag (515 total volume), Rx OnlyJuly 10, 2023
D-0926-2023Class IISUCCINYLcholine Chloride 200 mg/10mL (20 mg/mL), 10 mL BD Syringe, Rx Only, Advanced Compounding SolJuly 10, 2023
D-0778-2023Class IIIPhenylephrine HCl 20 mg added to 0.9% Sodium Chloride 250mL Bag, Rx Only, Compounded by: Advanced CoMay 22, 2023